drug
KITE-363
Phase 2updated 6mo agoby Kite Pharma Inc
Phase 2community read0 votes
indications
indications
DLBCL
all catalysts(0)
nothing on the calendar yet
Trials studying KITE-363
- —Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
- phase1A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- phase2Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
- phase1A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
News(1)
- Gilead reveals partial clinical hold on 2 CAR-T cell therapy trialsGilead Sciences announced on its third-quarter earnings call Oct. 29 that the company has placed a partial clinical hold on two studies for the CAR-T cell therapy KITE-753 in diffuse large B-cell l…fiercebiotech · 19d ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that